Amazon, Flipkart Among 20 E-Tailors Given Notices for Selling Drugs Without Licence
The notice states that the sale or stock or exhibit or offer for sale or distribution of any drug requires a licence from the concerned state licensing authority and conditions of a licence are required to be complied with by the licence holders.
Feb 12, 2023, 21:45 PM IST
Gambia cough syrup deaths: Govt panel says info shared by WHO so far inadequate to determine aetiology
Rutendo Kuwana from the WHO on October 13 had written to the DCGI seeking to know the progress with the investigation of the manufacturer of the four cough syrups -- the Sonipat-based Maiden Pharmaceuticals.
Oct 16, 2022, 00:46 AM IST
CORBEVAX becomes first vaccine in India to get DCGI approval for COVID-19 booster dose
CORBEVAX has become the first vaccine in India to get DCGI approval for COVID-19 booster dose.
Jun 04, 2022, 17:28 PM IST
Vaccine Breaking : DCGI grants emergency approval to Covaxin and Corbevax for children below 12
In India, now even 5-year-old children can be given vaccinated against coronavirus. Corbevax vaccine of Biological E Company has been approved for those between 5 to 12 years of age while Covaxin will be given to children between 6 to 12 years of age. These vaccines are administered in two doses each of which is given at an interval of 28 to 40 days
Apr 26, 2022, 15:30 PM IST
SII's Covid-19 vaccine ‘Covovax’ gets emergency use nod for children aged above 12 years
"Novavax in global trials has demonstrated more than 90 per cent efficacy. Serum Institute of India`s brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly," SII CEO Adar Poonawala said in a tweet.
Mar 09, 2022, 18:41 PM IST
Bharat Biotech gets DCGI nod to test nasal COVID-19 vaccine as booster shot
India's drug regulator DCGI on Wednesday granted approval to Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to news agency ANI.
Jan 05, 2022, 11:44 AM IST
Corbevax, Covovax, Molnupiravir: All about India's 3 new COVID19 vaccines, how they will be administered
Six COVID-19 vaccines - Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson - had already received EUA from the Indian drug regulator earlier.
Dec 29, 2021, 07:35 AM IST
Third jab soon? Serum Institute asks DCGI to allow Covishield as booster dose
SII cited adequate stock of the vaccine in the country and a demand for a booster.
Dec 01, 2021, 21:20 PM IST
Breaking News: Serum Institute seeks permission from DCGI for Booster Dose
Serum Institute sought permission from DCGI for Booster Dose. Serum Institute's vaccine is Covishield.
Dec 01, 2021, 20:42 PM IST
COVID-19: Covaxin recommended for 2 to 18-year-olds in India
The development comes amid India closing in on 100 crore vaccination coverage.
Oct 12, 2021, 13:31 PM IST
Centre forms panel to frame new law to regulate drugs, cosmetics, medical devices
The eight-member panel is expected to submit a draft document by November 30 that will help formulate the new Drugs, Cosmetics and Medical Devices Bill which could be taken up in the parliament to be enacted.
Sep 08, 2021, 16:03 PM IST
Serum Institute to produce Sputnik V vaccine from September
As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center, which developed the Sputnik V jab. After the approval by the Drug Controller General of India (DCGI), the cultivation process has begun.
Jul 13, 2021, 15:56 PM IST
Drug regulator DCGI gives nod for Sanofi-GSK's phase 3 trial of COVID vaccine in India
The French pharma company Sanofi and its British peer GSK aim to produce up to one billion doses in 2021.
Jul 08, 2021, 14:18 PM IST
COVID-19: Serum Institute gets DCGI nod to manufacture Sputnik V vaccine in India
SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility.
Jun 04, 2021, 20:36 PM IST
Serum Institute of India applies to DCGI to manufacture Sputnik V COVID vaccine, seeks indemnity
Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the SII has also sought protection against liabilities.
Jun 03, 2021, 12:32 PM IST
India to import vaccines to speed up vaccination of entire population
Govt. of India, through NEGVAC, is doing regular interaction with national and international vaccine manufacturers like Pfizer, Moderna etc. to make the COVID-19 vaccines available in-country.
May 28, 2021, 23:31 PM IST
Amphotericin B: Why is this drug important in Black Fungus treatment, what are its common side effects, Zee explains
The government is also actively exploring other global sources from where the Amphotericin-B drug can be imported, and the Union Health Ministry is also trying to procure other anti-fungal drugs that can be used in the treatment of Black Fungus.
May 24, 2021, 14:04 PM IST
DRDO's easily producible 2-DG drug helps in faster recovery of hospitalised COVID patients
A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.
May 10, 2021, 13:36 PM IST
COVID-19 Vaccine: DCGI approves anti-COVID drug developed by DRDO
The Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy’s Laboratories, Hyderabad, developed an anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG).
May 09, 2021, 10:24 AM IST
Covaxin and Covishield approved, know which is more effective in both vaccines and how much is the price?
DCGI on Sunday approved the emergency use of Covishield of Serum Institute and Bharat Biotech's Covaxin. Of which Covishield will be the first to start vaccination, Covaxin will remain as an option. The general public will get the vaccine by April - May.
Jan 04, 2021, 01:28 AM IST
